Intensive BP control did not cut CV events in diabetes

CHICAGO — Targeting systolic blood pressure of less than 120 mm Hg did not reduce major cardiovascular events in patients with diabetes and high CV risk vs. a target of less than 140 mm Hg.
The results of a prespecified meta-analysis indicated that intensive BP lowering may decrease risk for major CV events in this population, but the OPTIMAL-DIABETES trial was deemed neutral, according to data presented at the American Heart Association Scientific Sessions and simultaneously published in The New England Journal of Medicine.
“The optimal systolic blood pressure target in patients with type 2

Dermatologist debunks 8 Botox, filler myths on social media

SAN DIEGO — Injectables can deliver aesthetic benefits when performed properly, but misinformation on social media may deter patients from seeking treatment or encourage unsafe practices, according to a speaker.
“Social media has completely changed how patients learn about cosmetic procedures,” Susan L. Boone, MD, FAAD, FACMS, associate clinical professor of dermatology at UC Davis, told Healio. “Unfortunately, misinformation often spreads faster than science. When it comes to injectables, patients either fear looking overdone or believe injectables are simple, risk-free procedures anyone with

Why patients opt for conservative kidney management over dialysis

Older adults with end-stage kidney disease cited quality of life, declining health and seeing loved ones’ experiences as reasons for selecting conservative kidney management over dialysis, according to data published in JAMA Network Open.
Conservative kidney management, shared decision-making and advanced care planning have been increasingly recognized in nephrology guidelines but remain underutilized in practice, according to Michelle Prong Geiger, MD, resident physician in internal medicine-pediatrics at University of Rochester Medical Center, and colleagues. The researchers wanted to

Housing assistance in childhood has long-term health benefits

Receiving housing assistance during childhood is associated with reduced rates of diabetes and hypertension in adulthood, according to a study published in Health Affairs.
“There is a lot of evidence around childhood poverty and poor health outcomes, both during childhood and then later as an adult, regardless of your income as an adult,” Jeffrey D. Colvin, MD, JD, director of research in general academic pediatrics at Children’s Mercy Hospital in Kansas City, Missouri, told Healio in an interview. But most of this research stopped following outcomes after children reached adulthood, Colvin

Retina board addresses potential therapies for GA, inherited diseases

Click here to read the At Issue to this Healio Exclusive.
What treatments are on the horizon in retina, and how have new therapies shaped patient management in 2026?
Led by Section Editor Andrew A. Moshfeghi, MD, MBA, Healio | OSN Retina/Vitreous Board Members considered the latest issues in geographic atrophy. The participants highlighted future potential therapies as well as how to manage patients with inherited retinal diseases.
Moshfeghi: At this Healio | OSN Retina Roundtable, let's take the opportunity to talk about topics that are near and dear to our hearts in the field of retina and get

Molecular testing may stratify malignancy risk in thyroid nodules

PHILADELPHIA — Molecular testing may improve preoperative risk stratification in adults with indeterminate thyroid nodules and nodules with Bethesda V/VI cytology, according to findings from two posters.
In two retrospective analyses presented at the Annual Meeting of the American Thyroid Association, researchers from Henry Ford Health System evaluated molecular signatures from the Afirma Genomic Resource for Intelligent Discovery (GRID) database to determine whether they could help distinguish benign thyroid lesions from malignant ones and further characterize thyroid cancers according to the

Risk stratification before Charcot reconstruction lowers costs

Results showed coordinated care and early risk stratification may reduce “substantial” costs faced by patients with Charcot neuroarthropathy prior to midfoot reconstruction.
“Charcot neuroarthropathy has a large financial burden on the healthcare system, as well as plagues people physically, too. But we are finding that the per-patient average... is not distributed evenly, and it does not happen just at the time of surgery,” Kola D. George, MD, MPH, an orthopedic surgery resident physician at the Medical University of South Carolina, told Healio about results presented at the American

Large reduction in HAE attack rate with deucrictibant tablets

PHOENIX — More patients with hereditary angioedema receiving daily deucrictibant extended-release tablets as long-term prophylactic therapy had an at least 90% reduction in monthly attack rate vs. placebo, according to data presented here.
Researchers also found larger decreases in the rate of attacks treated with on-demand medication and the rate of moderate to severe attacks among those receiving deucrictibant (Pharvaris), an investigational bradykinin B2 receptor antagonist.
“We have some treatment options currently, and I think, if approved, this would add a really valuable tool to the

Universal germline genetic testing in cancer is ‘right move’

Use of a commonly used age-based cutoff for genetic testing among individuals with solid tumors resulted in a considerable proportion of inherited gene variants going undetected, according to study findings.
An analysis of nearly 40,000 people with a variety of cancer types showed restricting germline genetic sequencing to those aged younger than 50 years would have missed nearly three-quarters of individuals who harbored pathogenic variants.
This equates to a “missed opportunity” to obtain valuable information that could have profound implications for patients and their family members,

ACG guideline focuses on preventive care for cirrhosis

ACG has released a clinical guideline on preventive care for patients with cirrhosis, focused on mitigating risk for complications, infections and comorbidities with therapeutic and lifestyle interventions.
When deciding which key clinical issues to address, Elliot B. Tapper, MD, FAASLD, Andrews Family Research Professor of Hepatology and academic chief of hepatology at Michigan Medicine, said he and his colleagues considered how they could “help the most patients with cirrhosis with our limited time in clinic.”
“We focused on actionable items where care is known to fall short,” Tapper told